BLOG / 🇺🇸 United States · · daily

All HHS Contracts — August 20, 2026

All HHS Contracts

By Gunpowder Editorial ·

2 total filings analysed

Executive Summary

This digest covers two HHS contracts totaling $1.52B, with zero defense exposure, highlighting a dominant civilian agency theme. The standout signal is Emergent Product Development Gaithersburg Inc.'s $1.41B sole-source-like award from HHS, representing 93% of total value, which is a massive bullish signal for the company but carries concentration risk given its unknown competitive moat and pricing structure.

The second contract, Managed Care Advisors Inc.'s $107M CDC provider network deal, is neutral, offering stable multi-year revenue through November 2026 but with moderate competitive pressure from full-and-open competition. Key risk: Emergent's contract lacks transparency on pricing and competition, making it vulnerable to protests or budget scrutiny, while the CDC contract's time-and-materials pricing limits margin upside.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior All HHS Contracts digest from August 12, 2026.

Investment Signals (2)

  • Emergent Product Development Gaithersburg Inc. Secures $1.41B HHS Contract (MEDIUM)

    Emergent was awarded a $1.41B defense contract from HHS, the largest in this digest, signaling strong government demand for its products/services despite unknown competitive dynamics.

  • Managed Care Advisors Inc. Wins $107M CDC Provider Network Contract (HIGH)

    Managed Care Advisors secured a $107.3M definitive contract from the CDC for a nationwide provider network (WTCHP), with $106.9M already obligated, indicating near-full funding and stable execution.

Risk Flags (3)

  • Concentration [CRITICAL RISK]

    Emergent Product Development Gaithersburg Inc.'s $1.41B contract accounts for 93% of total digest value, creating extreme single-contract concentration risk for the company if funding is delayed or protested.

  • Execution [MEDIUM RISK]

    Managed Care Advisors Inc.'s contract uses time-and-materials pricing, which reduces margin risk but limits profit upside; full-and-open competition suggests potential for margin compression on future awards.

  • Budget [MEDIUM RISK]

    Both contracts are civilian HHS awards, making them vulnerable to discretionary budget cuts or Continuing Resolution delays, particularly if HHS faces sequestration or policy shifts.

Opportunities (2)

  • Emergent Product Development Gaithersburg Inc.'s $1.41B award suggests HHS is prioritizing medical countermeasure development, creating follow-on opportunities for similar biodefense contractors.

  • Managed Care Advisors Inc.'s $107M CDC contract runs through November 2026, with options for extension, providing a stable revenue base that could be leveraged for additional CDC or HHS contracts.

Sector Themes (2)

  • Both contracts are HHS awards totaling $1.52B, with zero defense exposure, indicating strong civilian agency spending on healthcare services and products, particularly for public health preparedness.

  • The digest shows a stark contrast: a single $1.41B award to Emergent (likely a large-cap) versus a $107M award to Managed Care Advisors (mid-cap), highlighting that smaller contractors face more competitive pressure.

Watch List (2)

  • 👁

    {"entity" => "Emergent Product Development Gaithersburg Inc.", "reason" => "The $1.41B HHS contract is massive but lacks transparency on pricing and competition, making it a key watch for protest risk or budget scrutiny.", "trigger" => "Protest filing or HHS budget hearing on medical countermeasure contracts"}

  • 👁

    {"entity" => "Managed Care Advisors, Inc.", "reason" => "The $107M CDC contract has near-full funding obligated, but the time-and-materials pricing and full competition signal potential margin pressure.", "trigger" => "CDC budget allocation for health insurance carrier services or competitor wins"}

Get daily alerts with 2 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 2 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: All HHS Contracts

🇺🇸 More from United States

View all →